Viewing nowOlmesartan Medoxomil 20 mg
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.

MFDS item code 201100906 · Approved 2011.02.24 · Insurance code 661903980
Treatment of essential hypertension
This medication is used to effectively control essential hypertension, which is an increase in blood pressure without a known cause. Maintaining blood pressure within the normal range is crucial for heart and vascular health; thus, this drug lowers blood pressure and dilates blood vessels, improving blood circulation. Regular use can help reduce the risk of complications associated with hypertension and maintain overall health. Therefore, it is used for the treatment of essential hypertension.
<Adults> The recommended initial dose is 10mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. In patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while closely monitoring their condition. <Elderly patients> No dosage adjustment is necessary when this medicine is administered to elderly patients aged 65 years or older. Although no overall differences in the efficacy or safety of this medicine have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and it may be increased to a maximum of 20mg daily. Use in patients with severe hepatic impairment is not recommended because there is no experience with its use in these patients.
Safety and efficacy in children have not been established.
This medication should not be given to women in the second and third trimesters of pregnancy. It carries the risk of serious damage or even death to the fetus or newborn. If pregnancy is confirmed, this medication must be discontinued immediately. It should not be used if there is an allergy to any ingredients contained in this medication. In addition, women who are pregnant or breastfeeding, patients undergoing kidney dialysis, patients with severe liver impairment, and patients with bile duct obstruction should not use this medication. Individuals with certain genetic disorders, such as lactose intolerance, should also not take this medication. Diabetic patients taking the medication aliskiren or those with moderate to severe kidney dysfunction should not use this drug concurrently. When this medication is first administered to patients with low blood volume or salt deficiency, blood pressure can drop suddenly; caution is required in these cases. The patient should be laid down, and if necessary, saline solution should be administered to stabilize blood pressure. Patients with severe heart failure and poor kidney function may experience worsening of kidney function when taking this medication, necessitating regular blood tests. Kidney transplant patients or patients with renal artery hypertension should also carefully monitor kidney function while taking this medication. Due to the risk of hyperkalemia, patients with heart or kidney conditions should have their serum potassium levels checked regularly. Special caution is required when prescribing this medication to patients with aortic stenosis, mitral valve stenosis, obstructive hypertrophic cardiomyopathy, or echocardiographic evidence of left ventricular outflow tract obstruction. Patients with primary aldosteronism may not respond well to this medication, and its use is not recommended. This medication lowers blood pressure, which may result in dizziness; therefore, caution should be exercised when driving or operating dangerous machinery. Common side effects that may occur during the use of this medication include dizziness, headache, back pain, dyspepsia, and cough, most of which are mild and temporary. Serious allergic reactions, such as facial swelling or angioedema, may occur in rare cases; any unusual symptoms should be reported to a healthcare professional immediately. Long-term use may rarely result in abnormal liver function tests or changes in blood test values, so regular testing is necessary. This medication may increase the blood pressure-lowering effect when taken with other antihypertensive drugs, so consultation with a healthcare provider is advised. Taking potassium-sparing diuretics or potassium supplements concurrently may raise potassium levels to dangerous levels, requiring caution. When combined with non-steroidal anti-inflammatory drugs, kidney function may worsen; therefore, adequate hydration and monitoring of kidney function are necessary. This medication may increase lithium levels when taken with lithium, leading to toxicity; therefore, concurrent use is not recommended. Taking this medication during pregnancy can lead to serious side effects for the fetus; therefore, it is essential to consult with a healthcare provider if pregnancy is planned or if the patient is pregnant. Women who are breastfeeding should be aware that this medication can be partially transmitted in breast milk, posing a risk of adverse reactions to the baby; thus, it is advisable to cease breastfeeding or discontinue the medication. Safety and efficacy in pediatric patients have not yet been established. Elderly patients may require dose adjustments due to altered drug metabolism; therefore, they should follow healthcare provider instructions regarding dosage. In case of overdose, symptoms such as hypotension or palpitations may appear, and in severe cases, bradycardia may occur, necessitating appropriate treatment based on the symptoms. No significant carcinogenic or genotoxic risks have been reported in carcinogenicity or genetic toxicity tests; however, any unusual reactions during clinical use should be reported to healthcare professionals immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is recommended to maintain storage temperatures between 1 degree and 30 degrees Celsius.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 20mg
Tablet · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.